Case Study 16.2 — Sam Okonkwo and the F31 Fellowship

A composite, illustrative case. Sam Okonkwo and the specifics are constructed to teach; the NIH fellowship structures and review emphases are real. Verify current details at grants.nih.gov.

Why a second case, and why a fellowship

Hernandez's R01 (Case Study 16.1) shows the workhorse mechanism from an independent investigator's chair. But most readers headed for NIH will start somewhere earlier on the arc — and the most important early lesson is that the F31 is a different animal from the R01, scored on different things. Apply R01 instincts to an F31 and you will misallocate your effort badly. Sam's case exists to make that difference concrete.

The trainee and the project

Sam Okonkwo is a third-year PhD student in a strong lab studying a focused dissertation question. Sam has a capable mentor, a clear training environment, and a well-scoped project — but not the kind of substantial preliminary data an independent investigator would bring, and that's entirely appropriate. Sam is a trainee, and the F31 predoctoral fellowship is designed precisely for this stage: it funds the development of the scientist, not the launch of an independent research program.

Run the threshold concept: match the mechanism to your stage and evidence, not your ambition. For a graduate student, an R01 would be absurd; the F31 fits Sam's stage exactly. Sam passes the test the way the chapter intends — by choosing the stage-appropriate mechanism rather than reaching past it.

What an F31 is actually judged on

Here is the crux, and the reason this case earns its place. The R01 is judged mainly on the research — the holistic impact of the proposed project. An F31 is judged on a different center of gravity: the candidate, the sponsor/mentor and training plan, the research training project, and the environment. In plain terms:

  • The candidate (Sam). Is this a promising trainee with the potential to become an independent, productive scientist? Sam's academic record, prior research, reference letters, and a personal statement of goals carry real weight — the person is under review in a way they are not for an R01.
  • The sponsor and training plan. Is the mentor well suited and well funded to train Sam? Is there a concrete, individualized training plan — coursework, skills, mentoring structure, milestones — that will develop Sam into an independent investigator? For an F31, the mentor's track record of training and the plan for Sam's development are central, not peripheral.
  • The research training project. The science matters — but explicitly as a vehicle for training. Reviewers ask whether the project is a good learning experience that will build Sam's skills, not whether it's a fundable independent research program. Substantial preliminary data is not expected.
  • The environment. Does the institution offer the resources, community, and structure to support Sam's training?

Sam writes accordingly. Instead of pouring everything into preliminary data (the R01 instinct), Sam invests in a compelling candidate statement, works with the mentor to build a genuinely individualized training plan, secures strong reference letters, and frames the research project as a training vehicle with appropriate (not overreaching) scope. The mentor's sponsor statement — describing the training environment, mentoring approach, and commitment — is treated as a core component, not an afterthought.

The review, and a resubmission

Sam's F31 goes to a fellowship review panel. The science is sound and the candidate is strong, but the first-round critique flags two things: the training plan is somewhat generic (it doesn't show clearly how this project develops this trainee's specific gaps), and the timeline/milestones are vague.

Notice what is not the main critique: nobody asks for more preliminary data or doubts the project's independent fundability — because that's not what an F31 is for. The feedback is about training, because training is what an F31 funds.

Sam treats this exactly as Hernandez treated her R01 summary statement (Section 16.6, Chapter 22): as the gift inside a rejection. The resubmission strengthens the training plan into a specific, milestone-driven developmental arc tied to Sam's actual skill gaps, sharpens the mentor's sponsor statement to match, and clarifies the timeline. The revised F31 — responsive, training-focused, with a now-concrete development plan — is funded.

What this case teaches

  1. Mechanism determines what's reviewed. The F31 and R01 share NIH's machinery (assignment, scoring, summary statements, resubmission) but are judged on different things. Bring R01 instincts (preliminary-data-maximalism) to an F31 and you under-invest in the candidate and training plan — the very things that decide it.
  2. The threshold concept, again. Sam's success starts with choosing the stage-appropriate mechanism. The most common early-career NIH error is reaching for a mechanism your stage and evidence don't fit; Sam avoids it.
  3. The mentor is part of the application. For training awards, the sponsor's record and the training plan are central. A weak or generic training plan sinks a strong candidate — so co-author it deliberately with your mentor.
  4. Resubmission is the norm at every level. Sam's funded F31, like Hernandez's funded R01, came on a responsive resubmission. The A1 path is not just for big grants; it's how NIH funding works up and down the mechanism arc.

🚪 Threshold reminder: Sam (F31) and Hernandez (R01) made different right choices because their stages and evidence differed. That is the threshold concept in action — and the proof that "which mechanism?" is answered by where you are, not by what you want.

🔄 Retrieve: Name the four things an F31 is centrally judged on, and explain why "more preliminary data" was not the fix Sam's resubmission needed. (Answers above.)